Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Am J Respir Crit Care Med ; 201(7): 789-798, 2020 04 01.
Article in English | MEDLINE | ID: mdl-31910037

ABSTRACT

Rationale: Although proposed as a clinical prompt to sepsis based on predictive validity for mortality, the Quick Sepsis-related Organ Failure Assessment (qSOFA) score is often used as a screening tool, which requires high sensitivity.Objectives: To assess the predictive accuracy of qSOFA for mortality in Brazil, focusing on sensitivity.Methods: We prospectively collected data from two cohorts of emergency department and ward patients. Cohort 1 included patients with suspected infection but without organ dysfunction or sepsis (22 hospitals: 3 public and 19 private). Cohort 2 included patients with sepsis (54 hospitals: 24 public and 28 private). The primary outcome was in-hospital mortality. The predictive accuracy of qSOFA was examined considering only the worst values before the suspicion of infection or sepsis.Measurements and Main Results: Cohort 1 contained 5,460 patients (mortality rate, 14.0%; 95% confidence interval [CI], 13.1-15.0), among whom 78.3% had a qSOFA score less than or equal to 1 (mortality rate, 8.3%; 95% CI, 7.5-9.1). The sensitivity of a qSOFA score greater than or equal to 2 for predicting mortality was 53.9% and the 95% CI was 50.3 to 57.5. The sensitivity was higher for a qSOFA greater than or equal to 1 (84.9%; 95% CI, 82.1-87.3), a qSOFA score greater than or equal to 1 or lactate greater than 2 mmol/L (91.3%; 95% CI, 89.0-93.2), and systemic inflammatory response syndrome plus organ dysfunction (68.7%; 95% CI, 65.2-71.9). Cohort 2 contained 4,711 patients, among whom 62.3% had a qSOFA score less than or equal to 1 (mortality rate, 17.3%; 95% CI, 15.9-18.7), whereas in public hospitals the mortality rate was 39.3% (95% CI, 35.5-43.3).Conclusions: A qSOFA score greater than or equal to 2 has low sensitivity for predicting death in patients with suspected infection in a developing country. Using a qSOFA score greater than or equal to 2 as a screening tool for sepsis may miss patients who ultimately die. Using a qSOFA score greater than or equal to 1 or adding lactate to a qSOFA score greater than or equal to 1 may improve sensitivity.Clinical trial registered with www.clinicaltrials.gov (NCT03158493).


Subject(s)
Organ Dysfunction Scores , Sepsis/diagnosis , Adult , Aged , Aged, 80 and over , Brazil , Cohort Studies , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Reproducibility of Results , Time Factors
2.
Am J Hosp Palliat Care ; 37(8): 594-599, 2020 Aug.
Article in English | MEDLINE | ID: mdl-31726853

ABSTRACT

PURPOSE: To examine quality indicators of end-of-life (EOL) care among privately insured people with cancer in Brazil. METHODS: We evaluated medical records linked to health insurance databank to study consecutive patients who died of cancer. We collected information about demographics, cancer type, and quality indicators of EOL care including emergency department (ED) visits, intensive care unit (ICU) admissions, chemotherapy use, medical imaging utilization, blood transfusions, home care support, days of inpatient care, and hospital deaths. RESULTS: We included 865 patients in the study. In the last 30 days of life, 62% visited the ED, 33% were admitted to the ICU, 24% received blood transfusions, and 51% underwent medical imaging. Only 1% had home care support in the last 60 days of life, and 29% used chemotherapy in the last 14 days of life. Patients had an average of 8 days of inpatient care and 52% died in the hospital. Patients with advanced cancer who used chemotherapy were more likely to visit the ED (78% vs 59%; P < .001), undergo medical imaging (67% vs 51%; P < .001), and die in the hospital (73% vs 50%; P = .03) than patients who did not use chemotherapy. In the multivariate analysis, chemotherapy use near death and advanced cancer were associated with ED visits and ICU admissions, respectively (odds ratio >1). CONCLUSION: Our study suggests that privately insured people with cancer receive poor quality EOL care in Brazil. Further research is needed to assess the impact of improvements in palliative care provision in this population.


Subject(s)
Insurance, Health/statistics & numerical data , Neoplasms/epidemiology , Patient Acceptance of Health Care/statistics & numerical data , Private Sector/statistics & numerical data , Quality of Health Care/statistics & numerical data , Terminal Care/statistics & numerical data , Aged , Aged, 80 and over , Antineoplastic Agents/adverse effects , Brazil , Female , Health Services/statistics & numerical data , Home Care Services/statistics & numerical data , Hospitalization/statistics & numerical data , Humans , Middle Aged , Neoplasms/drug therapy , Palliative Care/statistics & numerical data , Quality Indicators, Health Care , Retrospective Studies , Severity of Illness Index , Socioeconomic Factors
3.
Am J Hosp Palliat Care ; 36(9): 775-779, 2019 Sep.
Article in English | MEDLINE | ID: mdl-30744400

ABSTRACT

Patients with hematologic malignancies (HMs) often receive poor-quality end-of-life care. This study aimed to identify trends in end-of-life care among patients with HM in Brazil. We conducted a retrospective cohort study (2015-2018) of patients who died with HM, using electronic medical records linked to health insurance databank, to evaluate outcomes consistent with health-care resource utilization at the end of life. Among 111 patients with HM, in the last 30 days of life, we found high rates of emergency department visits (67%, n = 75), intensive care unit admissions (56%, n = 62), acute renal replacement therapy (10%, n = 11), blood transfusions (45%, n = 50), and medical imaging utilization (59%, n = 66). Patients received an average of 13 days of inpatient care and the majority of them died in the hospital (53%, n = 58). We also found that almost 40% of patients (38%, n = 42) used chemotherapy in the last 14 days of life. These patients were more likely to be male (64% vs 22%; P < .001), to receive blood transfusions (57% vs 38%; P = .05), and to die in the hospital (76% vs 39%; P = .009) than patients who did not use chemotherapy in the last 14 days of life. This study suggests that patients with HM have high rates of health-care utilization at the end of life in Brazil. Patients who used chemotherapy in the last 14 days of life were more likely to receive blood transfusions and to die in the hospital.


Subject(s)
Hematologic Neoplasms/therapy , Patient Acceptance of Health Care/statistics & numerical data , Aged , Aged, 80 and over , Brazil , Female , Health Resources/statistics & numerical data , Hospice Care/trends , Hospitalization/trends , Humans , Male , Middle Aged , Palliative Care/trends , Retrospective Studies , Sex Factors , Terminal Care/trends
4.
Ann Palliat Med ; 7(4): 437-443, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29860860

ABSTRACT

BACKGROUND: As death approaches, there may be similarities in terms of physical symptoms among dementia and cancer. This study aimed to estimate the prevalence and intensity of dyspnea, pain, and agitation among people dying with late stage dementia versus those dying with advanced cancer. Methods: A retrospective analysis, conducted in a post-acute care facility (PACF) in Rio de Janeiro, Brazil. We reviewed the electronic charts for the Edmonton Symptom Assessment System (ESAS) scores, from death backwards in time (3 days). METHODS: A retrospective analysis, conducted in a post-acute care facility (PACF) in Rio de Janeiro, Brazil. We reviewed the electronic charts for the Edmonton Symptom Assessment System (ESAS) scores, from death backwards in time (3 days). RESULTS: We included 57 patients who died with dementia and 54 patients who died with cancer. The prevalence of dyspnea (dementia: n=34, 60% vs. cancer: n=39, 72%; P=0.23), and agitation (dementia: n=7, 13% vs. cancer: n=14, 25%; P=0.17) were statically similar between the two groups. Pain was less common in dementia (dementia: n=19, 34% vs. cancer: n=31, 57%; P=0.02). There were no significant differences in the percentage of patients with moderate to severe dyspnea (dementia: n=28, 49% vs. cancer: n=33, 61%; P=0.28), and moderate to severe agitation (dementia: n=4, 7% vs. cancer: n=12, 23%; P=0.09). Dementia patients were less likely to experience moderate to severe pain than cancer patients (dementia: n=14, 25% vs. cancer: n=25, 46%; P=0.03). The diagnosis of cancer was independently associated with pain, severe symptoms, and the co-occurrence of dyspnea, pain, and agitation (odds ratio >1). CONCLUSIONS: People dying with dementia and those dying with cancer experienced similar rates of dyspnea, and agitation. However, pain was significantly more prevalent and intense among people dying with cancer.


Subject(s)
Dementia/psychology , Neoplasms/psychology , Palliative Care , Adult , Aged , Aged, 80 and over , Anxiety/epidemiology , Brazil/epidemiology , Dyspnea/epidemiology , Female , Humans , Male , Medical Records , Middle Aged , Pain Measurement , Pain, Intractable/epidemiology , Prevalence , Retrospective Studies
5.
BMJ Open ; 8(1): e018541, 2018 01 24.
Article in English | MEDLINE | ID: mdl-29371274

ABSTRACT

INTRODUCTION: Higher mortality for patients admitted to intensive care units (ICUs) during the weekends has been occasionally reported with conflicting results that could be related to organisational factors. We investigated the effects of ICU organisational and staffing patterns on the potential association between weekend admission and outcomes in critically ill patients. METHODS: We included 59 614 patients admitted to 78 ICUs participating during 2013. We defined 'weekend admission' as any ICU admission from Friday 19:00 until Monday 07:00. We assessed the association between weekend admission with hospital mortality using a mixed logistic regression model controlling for both patient-level (illness severity, age, comorbidities, performance status and admission type) and ICU-level (decrease in nurse/bed ratio on weekend, full-time intensivist coverage, use of checklists on weekends and number of institutional protocols) confounders. We performed secondary analyses in the subgroup of scheduled surgical admissions. RESULTS: A total of 41 894 patients (70.3%) were admitted on weekdays and 17 720 patients (29.7%) on weekends. In univariable analysis, weekend admitted patients had higher ICU (10.9% vs 9.0%, P<0.001) and hospital (16.5% vs 13.5%, P<0.001) mortality. After adjusting for confounders, weekend admission was not associated with higher hospital mortality (OR 1.05, 95% CI 0.99 to 1.12, P=0.095). However, a 'weekend effect' was still observed in scheduled surgical admissions, as well as in ICUs not using checklists during the weekends. For unscheduled admissions, no 'weekend effect' was observed regardless of ICU's characteristics. For scheduled surgical admissions, a 'weekend effect' was present only in ICUs with a low number of implemented protocols and those with a reduction in the nurse/bed ratio and not applying checklists during weekends. CONCLUSIONS: ICU organisational factors, such as decreased nurse-to-patient ratio, absence of checklists and fewer standardised protocols, may explain, in part, increases in mortality in patients admitted to the ICU mortality on weekends.


Subject(s)
Critical Illness/mortality , Hospital Mortality/trends , Intensive Care Units , Patient Admission/statistics & numerical data , Adult , Aged , Aged, 80 and over , Brazil , Critical Illness/therapy , Female , Humans , Intensive Care Units/organization & administration , Logistic Models , Male , Middle Aged , Multivariate Analysis , Propensity Score , Retrospective Studies , Time Factors , Workforce
6.
Am J Hosp Palliat Care ; 35(2): 198-202, 2018 Feb.
Article in English | MEDLINE | ID: mdl-28135810

ABSTRACT

Patients with complex palliative care needs can experience delayed discharge, which causes an inappropriate occupancy of hospital beds. Post-acute care facilities (PACFs) have emerged as an alternative discharge destination for some of these patients. The aim of this study was to investigate the frequency of admissions and characteristics of palliative care patients discharged from hospitals to a PACF. We conducted a retrospective analysis of PACF admissions between 2014 and 2016 that were linked to hospital discharge reports and electronic health records, to gather information about hospital-to-PACF transitions. In total, 205 consecutive patients were discharged from 6 different hospitals to our PACF. Palliative care patients were involved in 32% (n = 67) of these discharges. The most common conditions were terminal cancer (n = 42, 63%), advanced dementia (n = 17, 25%), and stroke (n = 5, 8%). During acute hospital stays, patients with cancer had significant shorter lengths of stay (13 vs 99 days, P = .004), a lower use of intensive care services (2% vs 64%, P < .001) and mechanical ventilation (2% vs 40%, P < .001), when compared to noncancer patients. Approximately one-third of discharges from hospitals to a PACF involved a heterogeneous group of patients in need of palliative care. Further studies are necessary to understand the trajectory of posthospitalized patients with life-limiting illnesses and what factors influence their decision to choose a PACF as a discharge destination and place of death. We advocate that palliative care should be integrated into the portfolio of post-acute services.


Subject(s)
Hospitals, Special/organization & administration , Palliative Care/organization & administration , Terminal Care/organization & administration , Adult , Aged , Aged, 80 and over , Brazil , Humans , Length of Stay , Middle Aged , Patient Care Planning/organization & administration , Patient Care Team/organization & administration , Patient Discharge , Respiration, Artificial/statistics & numerical data , Retrospective Studies , Severity of Illness Index , Socioeconomic Factors
7.
Trop Med Int Health ; 22(10): 1314-1321, 2017 10.
Article in English | MEDLINE | ID: mdl-28805026

ABSTRACT

OBJECTIVES: To evaluate the correlation of the total distance walked during the six-minute walk test (6MWT) with left ventricular function and quality of life in patients with Chagas Disease (ChD) complicated by heart failure. METHODS: This is a cross-sectional study of adult patients with ChD and heart failure diagnosed based on Framingham criteria. 6MWT was performed following international guidelines. New York Heart Association functional class, brain natriuretic peptide (BNP) serum levels, echocardiographic parameters and quality of life (SF-36 and MLHFQ questionnaires) were determined and their correlation with the distance covered at the 6MWT was tested. RESULTS: Forty adult patients (19 male; 60 ± 12 years old) with ChD and heart failure were included in this study. The mean left ventricular ejection fraction was 35 ± 12%. Only two patients (5%) ceased walking before 6 min had elapsed. There were no cardiac events during the test. The average distance covered was 337 ± 105 metres. The distance covered presented a negative correlation with BNP (r = -0.37; P = 0.02), MLHFQ quality-of-life score (r = -0.54; P = 0.002), pulmonary artery systolic pressure (r = -0.42; P = 0.02) and the degree of diastolic dysfunction (r = -0.36; P = 0.03) and mitral regurgitation (r = -0.53; P = 0.0006) and positive correlation with several domains of the SF-36 questionnaire. CONCLUSIONS: The distance walked during the 6MWT correlates with BNP, quality of life and parameters of left ventricular diastolic function in ChD patients with heart failure. We propose this test to be adopted in endemic areas with limited resources to aid in the identification of patients who need referral for tertiary centres for further evaluation and treatment.


Subject(s)
Chagas Disease/complications , Heart Failure/physiopathology , Quality of Life , Ventricular Function, Left/physiology , Walk Test , Chagas Disease/physiopathology , Cross-Sectional Studies , Echocardiography , Female , Heart Failure/diagnostic imaging , Heart Failure/etiology , Humans , Immunoenzyme Techniques , Male , Middle Aged , Natriuretic Peptide, Brain/analysis
8.
J Acquir Immune Defic Syndr ; 75(4): e90-e98, 2017 08 01.
Article in English | MEDLINE | ID: mdl-28291051

ABSTRACT

BACKGROUND: The 30-day readmission rate is an indicator of the quality of hospital care and transition to the outpatient setting. Recent studies suggest HIV infection might increase the risk of readmission although estimates of 30-day readmission rates are unavailable among HIV-infected individuals living in middle/low-income settings. Additionally, factors that may increase readmission risk in HIV-infected populations are poorly understood. METHODS: Thirty-day readmission rates were estimated for HIV-infected adults from the Instituto Nacional de Infectologia Evandro Chagas/Fiocruz cohort in Rio de Janeiro, Brazil, from January 2007 to December 2013. Cox regression models were used to evaluate factors associated with the risk of 30-day readmission. RESULTS: Between January 2007 and December 2013, 3991 patients were followed and 1861 hospitalizations were observed. The estimated 30-day readmission rate was 14% (95% confidence interval: 12.3 to 15.9). Attending a medical visit within 30 days after discharge (adjusted hazard ratio [aHR] = 0.73, P = 0.048) and being hospitalized in more recent calendar years (aHR = 0.89, P = 0.002) reduced the risk of 30-day readmission. In contrast, low CD4 counts (51-200 cells/mm³: aHR = 1.70, P = 0.024 and ≤ 50 cells/mm³: aHR = 2.05, P = 0.003), time since HIV infection diagnosis ≥10 years (aHR = 1.58, P = 0.058), and leaving hospital against medical advice (aHR = 2.67, P = 0.004) increased the risk of 30-day readmission. CONCLUSIONS: Patients with advanced HIV/AIDS are most at risk of readmission and should be targeted with prevention strategies to reduce this risk. Efforts to reduce discharge against medical advice and to promote early postdischarge medical visit would likely reduce 30-day readmission rates in our population.


Subject(s)
HIV Infections/physiopathology , Hospitalization/statistics & numerical data , Length of Stay/statistics & numerical data , Patient Readmission , Quality of Health Care/statistics & numerical data , Adult , Brazil/epidemiology , CD4 Lymphocyte Count , Female , HIV Infections/drug therapy , HIV Infections/epidemiology , Humans , Male , Middle Aged , Patient Readmission/statistics & numerical data , Proportional Hazards Models , Risk Factors , Viral Load
9.
Ann Am Thorac Soc ; 13(10): 1775-1783, 2016 10.
Article in English | MEDLINE | ID: mdl-27463839

ABSTRACT

RATIONALE: Pressure ulcers are preventable events. Critically ill patients are particularly vulnerable. The Braden scale has been used to identify hospitalized patients at high risk for the development of pressure ulcers; however, this predictive tool has not been adequately validated for critically ill patients. OBJECTIVES: We aimed to validate and improve the Braden scale for critically ill patients by adding clinical variables to the original scale. METHODS: We conducted a cohort study in 12 intensive care units (ICUs) within a network of hospitals in Brazil during 2013. We excluded patients who stayed less than 48 hours, patients with one or more pressure ulcers at admission, and those who developed a pressure ulcer within the first 48 hours. We evaluated the Braden scale and clinical variables through a competing risk analysis. Discrimination and calibration were evaluated using the Concordance index (C-index) and a calibration plot, respectively. We used bootstrapping to assess internal validation. MEASUREMENTS AND MAIN RESULTS: Our primary outcome was incident pressure ulcer within 30 days of ICU admission. We analyzed 9,605 patients and observed 157 pressure ulcers (rate of 3.33 pressure ulcers/1,000 patient-days). The majority of pressure ulcers were detected at stage I or II (28.7 and 66.2%, respectively). The Braden scale had good discrimination (C-index, 0.753; 95% confidence interval, 0.712-0.795), although its performance decreased for the most severely ill patients. We derived a modified predictive tool by adding eight clinical variables to the Braden scale: age, sex, diabetes mellitus, hematological malignancy, peripheral artery disease, hypotension at ICU admission, and need for mechanical ventilation or renal replacement therapy in the first 24 hours after ICU admission. The derived score had better discrimination and calibration than the original Braden scale. The best score cutoff was at least 6 points, with a sensitivity of 87% and a specificity of 71%. CONCLUSIONS: The original Braden scale measured at ICU admission is a valuable tool for pressure ulcer prediction, although it is not accurate for severely ill patients. To overcome the limitations of the original scale, we derived a modified score with better performance, which may identify high-risk ICU patients and support target interventions. External validation of the proposed clinical prediction score is needed.


Subject(s)
Intensive Care Units/statistics & numerical data , Pressure Ulcer/diagnosis , Pressure Ulcer/epidemiology , Adult , Aged , Aged, 80 and over , Brazil/epidemiology , Cohort Studies , Critical Illness , Female , Hospital Mortality , Humans , Male , Middle Aged , Predictive Value of Tests , Risk Assessment , Risk Factors , Severity of Illness Index , Time Factors
10.
BMC Infect Dis ; 16: 270, 2016 06 10.
Article in English | MEDLINE | ID: mdl-27286652

ABSTRACT

BACKGROUND: Tuberculosis is one of the leading causes of death from infectious diseases worldwide, mainly after the human immunodeficiency virus (HIV) epidemics. Patient with HIV-related illness are more likely to present with severe TB due to immunosuppression. Very few studies have explored HIV/TB co-infection in critically ill patients. The goal of this study was to analyze factors associated with long-term mortality in critically ill patient with HIV-related disease coinfected with TB. METHODS: We conducted a retrospective study in an infectious disease reference center in Brazil that included all patient with HIV-related illness admitted to the ICU with laboratory-confirmed tuberculosis from March 2007 until June 2012. Clinical and laboratory variables were analyzed based on six-month survival. RESULTS: Forty-four patients with HIV-related illness with a confirmed diagnosis of tuberculosis were analyzed. The six-month mortality was 52 % (23 patients). The main causes of admission were respiratory failure (41 %), severe sepsis/septic shock (32 %) and coma/torpor (14 %). The median time between HIV diagnosis and ICU admission was 5 (1-60) months, and 41 % of patients received their HIV infection diagnosis ≤ 30 days before admission. The median CD4 count was 72 (IQR: 23-136) cells/mm(3). The clinical presentation was pulmonary tuberculosis in 22 patients (50 %) and disseminated TB in 20 patients (45.5 %). No aspect of TB diagnosis or treatment was different between survivors and nonsurvivors. Neurological dysfunction was more prevalent among nonsurvivors (43 % vs. 14 %, p = 0.04). The nadir CD4 cell count lower than 50 cells/mm(3) was independently associated with Six-month mortality (hazard ratio 4.58 [1.64-12.74], p < 0.01), while HIV diagnosis less than three months after positive serology was protective (hazard ratio 0.27, CI 95 % [0.10-0.72], p = 0.01). CONCLUSION: The Six-month mortality of HIV critically ill patients with TB coinfection is high and strongly associated with the nadir CD4 cell count less than 50 cels/mm(3).


Subject(s)
Coinfection/mortality , Critical Illness/mortality , HIV Infections/mortality , Respiratory Insufficiency/mortality , Sepsis/mortality , Tuberculosis, Pulmonary/mortality , Adult , Brazil/epidemiology , CD4 Lymphocyte Count , Coinfection/epidemiology , Comorbidity , Critical Illness/epidemiology , Female , HIV Infections/diagnosis , HIV Infections/epidemiology , HIV Infections/immunology , Hospitalization , Humans , Intensive Care Units , Male , Middle Aged , Mortality , Organ Dysfunction Scores , Proportional Hazards Models , Respiratory Insufficiency/epidemiology , Retrospective Studies , Risk Factors , Sepsis/epidemiology , Time Factors , Tuberculosis/mortality , Tuberculosis, Pulmonary/epidemiology , Young Adult
11.
Intensive Care Med ; 41(12): 2149-60, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26499477

ABSTRACT

PURPOSE: Detailed information on organization and process of care in intensive care units (ICU) in emerging countries is scarce. Here, we investigated the impact of organizational factors on the outcomes and resource use in a large sample of Brazilian ICUs. METHODS: Retrospective cohort study of 59,693 patients (medical admissions, 67 %) admitted to 78 ICUs during 2013. We retrieved patients' data from an ICU quality registry and surveyed ICUs regarding structure, organization, staffing patterns, and process of care. We used multilevel logistic regression analysis to identify factors associated with hospital mortality. Efficient resource use was assessed by estimating standardized resource use and mortality rates adjusted for the SAPS 3 score. RESULTS: ICUs were mostly medical-surgical (79 %) and located at private hospitals (86 %). Median nurse to bed ratio was 0.20 (IQR, 0.15-0.28) and board-certified intensivists were present 24/7 in 16 (21 %) of ICUs. Multidisciplinary rounds occurred in 67 (86 %) and daily checklists were used in 36 (46 %) ICUs. Most frequent protocols focused on sepsis management and prevention of healthcare-associated infections. Hospital mortality was 14.4 %. In multivariable analysis, the number of protocols was the only organizational characteristic associated with mortality [odds ratio = 0.944 (95 % CI 0.904-0.987)]. The effects of protocols were consistent across subgroups including surgical and medical patients as well as the SAPS 3 tertiles. We also observed a significant trend toward efficient resource use as the number of protocols increased. CONCLUSIONS: In emerging countries such as Brazil, organizational factors, including the implementation of protocols, are potential targets to improve patient outcomes and resource use in ICUs.


Subject(s)
Health Resources/statistics & numerical data , Hospital Mortality , Intensive Care Units/organization & administration , Adult , Aged , Aged, 80 and over , Brazil , Cohort Studies , Female , Humans , Male , Middle Aged , Retrospective Studies
12.
Respir Care ; 59(12): 1888-94, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25118312

ABSTRACT

BACKGROUND: Evidence exists that during pressure support ventilation (PSV), the addition of an extrinsic (ie, ventilator-generated) breath-to-breath variability (BBV) of breathing pattern improves respiratory function. If BBV is beneficial per se, choosing the PS level that maximizes it could be considered a valid strategy for conventional PSV. In this study, we evaluated the effect of different PS levels on intrinsic BBV in acutely ill, mechanically ventilated subjects to determine whether a significant relationship exists between PS level and BBV magnitude. METHODS: Fourteen invasively mechanically ventilated subjects were prospectively studied. PS was adjusted at 20 cm H2O and sequentially reduced to 15, 10, and 5 cm H2O. Arterial blood gas analysis and pressure at 0.1 s after the onset of inspiration (P0.1) were measured at each PS level. Airway and esophageal pressure and air flow were continuously recorded. Peak inspiratory flow, tidal volume (VT), breathing frequency, and pressure-time product (PTP) were calculated on a breath-by-breath basis. The breathing pattern variability was assessed by the coefficient of variation of the time series of VT, peak inspiratory flow, and breathing frequency from ∼ 60 consecutive breath cycles at each PS level. A general linear model for repeated measures was applied, with PS as an independent factor. A significance level of .05 was considered. RESULTS: Despite a large inter-individual difference in all measured variables (P < .001), the coefficient of variation was as low as 30%, and no significant differences in the coefficient of variation of peak inspiratory flow, breathing frequency, and VT between PS levels were observed (P > .15). Additionally, a significant increase in P0.1, PTP, and breathing frequency (P < .01) and a reduction in VT (P < .001) were observed with PS reduction. CONCLUSIONS: Despite a significant increase in spontaneous activity with PS reduction, BBV was not influenced by the PS level and was as low as 30% for all evaluated parameters.


Subject(s)
Pressure , Respiration, Artificial/methods , Respiration , Respiratory Insufficiency/therapy , Adult , Aged , Blood Gas Analysis , Esophagus , Humans , Middle Aged , Prospective Studies , Pulmonary Ventilation , Respiratory Insufficiency/physiopathology , Respiratory Rate , Tidal Volume , Time Factors
13.
PLoS One ; 8(7): e68730, 2013.
Article in English | MEDLINE | ID: mdl-23874739

ABSTRACT

INTRODUCTION: In recent years, the incidence of sepsis has increased in critically ill HIV/AIDS patients, and the presence of severe sepsis emerged as a major determinant of outcomes in this population. The inflammatory response and deregulated cytokine production play key roles in the pathophysiology of sepsis; however, these mechanisms have not been fully characterized in HIV/AIDS septic patients. METHODS: We conducted a prospective cohort study that included HIV/AIDS and non-HIV patients with septic shock. We measured clinical parameters and biomarkers (C-reactive protein and cytokine levels) on the first day of septic shock and compared these parameters between HIV/AIDS and non-HIV patients. RESULTS: We included 30 HIV/AIDS septic shock patients and 30 non-HIV septic shock patients. The HIV/AIDS patients presented low CD4 cell counts (72 [7-268] cells/mm(3)), and 17 (57%) patients were on HAART before hospital admission. Both groups were similar according to the acute severity scores and hospital mortality. The IL-6, IL-10 and G-CSF levels were associated with hospital mortality in the HIV/AIDS septic group; however, the CRP levels and the surrogates of innate immune activation (cytokines) were similar among HIV/AIDS and non-HIV septic patients. Age (odds ratio 1.05, CI 95% 1.02-1.09, p=0.002) and the IL-6 levels (odds ratio 1.00, CI 95% 1.00-1.01, p=0.05) were independent risk factors for hospital mortality. CONCLUSIONS: IL-6, IL-10 and G-CSF are biomarkers that can be used to predict prognosis and outcomes in HIV/AIDS septic patients. Although HIV/AIDS patients are immunocompromised, an innate immune response can be activated in these patients, which is similar to that in the non-HIV septic population. In addition, age and the IL-6 levels are independent risk factors for hospital mortality irrespective of HIV/AIDS disease.


Subject(s)
Acquired Immunodeficiency Syndrome/immunology , HIV Infections/immunology , Sepsis/immunology , Shock, Septic/immunology , Adult , Aged , Aged, 80 and over , Biomarkers/metabolism , C-Reactive Protein/immunology , C-Reactive Protein/metabolism , CD4 Lymphocyte Count/methods , Cohort Studies , Critical Illness , Cytokines/immunology , Cytokines/metabolism , Female , Granulocyte Colony-Stimulating Factor/immunology , Granulocyte Colony-Stimulating Factor/metabolism , Hospital Mortality , Humans , Immunity, Innate , Interleukin-10/immunology , Interleukin-10/metabolism , Interleukin-6/immunology , Interleukin-6/metabolism , Male , Middle Aged , Prospective Studies
15.
Crit Care Med ; 39(5): 1056-63, 2011 May.
Article in English | MEDLINE | ID: mdl-21336129

ABSTRACT

OBJECTIVE: Increasing evidence points to the role of mitochondrial dysfunction in the pathogenesis of sepsis. Previous data indicate that mitochondrial function is affected in monocytes from septic patients, but the underlying mechanisms and the impact of these changes on the patients' outcome are unknown. We aimed to determine the mechanisms involved in mitochondrial dysfunction in peripheral blood mononuclear cells from patients with septic shock. DESIGN: A cohort of patients with septic shock to study peripheral blood mononuclear cell mitochondrial respiration by high-resolution respirometry analyses and to compare with cells from control subjects. SETTING: Three intensive care units and an academic research laboratory. SUBJECTS: Twenty patients with septic shock and a control group composed of 18 postoperative patients without sepsis or shock. INTERVENTIONS: Ex vivo measurements of mitochondrial oxygen consumption were carried out in digitonin-permeabilized peripheral blood mononuclear cells from 20 patients with septic shock taken during the first 48 hrs after intensive care unit admission as well as in peripheral blood mononuclear cells from control subjects. Clinical parameters such as hospital outcome and sepsis severity were also analyzed and the relationship between these parameters and the oxygen consumption pattern was investigated. MEASUREMENTS AND MAIN RESULTS: We observed a significant reduction in the respiration specifically associated with adenosine-5'-triphosphate synthesis (state 3) compared with the control group (5.60 vs. 9.89 nmol O2/min/10(7) cells, respectively, p < .01). Reduction of state 3 respiration in patients with septic shock was seen with increased prevalence of organ failure (r = -0.46, p = .005). Nonsurviving patients with septic shock presented significantly lower adenosine diphosphate-stimulated respiration when compared with the control group (4.56 vs. 10.27 nmol O2/min/10(7) cells, respectively; p = .004). Finally, the presence of the functional F1Fo adenosine-5'-triphosphate synthase complex (0.51 vs. 1.00 ng oligo/mL/10(6) cells, p = .02), but not the adenine nucleotide translocator, was significantly lower in patients with septic shock compared with control cells. CONCLUSION: Mitochondrial dysfunction is present in immune cells from patients with septic shock and is characterized as a reduced respiration associated to adenosine-5'-triphosphate synthesis. The molecular basis of this phenotype involve a reduction of F1Fo adenosine-5'-triphosphate synthase activity, which may contribute to the energetic failure found in sepsis.


Subject(s)
Leukocytes, Mononuclear/cytology , Mitochondria/enzymology , Mitochondrial Proton-Translocating ATPases/metabolism , Shock, Septic/blood , Aged , Aged, 80 and over , Analysis of Variance , Case-Control Studies , Cells, Cultured , Energy Metabolism , Female , Humans , Intensive Care Units , Leukocytes, Mononuclear/physiology , Male , Middle Aged , Mitochondria/metabolism , Monocytes/cytology , Monocytes/physiology , Reference Values , Shock, Septic/enzymology
16.
Diagn Microbiol Infect Dis ; 68(4): 449-55, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20884155

ABSTRACT

The aim of this study was to investigate Clostridium difficile-associated diarrhea (CDAD) in an intensive care unit (ICU) of a tertiary hospital in Rio de Janeiro, Brazil, and to characterize epidemiologically C. difficile strains obtained from an outbreak of CDAD. Within almost a 4-year surveillance period, CDAD incidence was determined for the first time in Brazil, and a 3-fold increase was observed in the average rate of CDAD, featuring an outbreak. About 80% of the patients were over 65 years. The main antibiotic that could be probably associated to CDAD was piperacillin/tazobactam. Four toxigenic strains were isolated, 3 from stools and 1 from environmental samples. They were all resistant to clindamycin and fluoroquinolones. Fingerprinting analysis revealed their distribution between 2 different polymerase chain reaction ribotypes, with one of them being exclusively found in Brazil. It was possible to detect cross-infection and environmental contamination in the ICU. Our results highlight the importance of a continuous CDAD surveillance in the hospitals, especially when a risk group is exposed.


Subject(s)
Clostridioides difficile/isolation & purification , Cross Infection/epidemiology , Diarrhea/epidemiology , Disease Outbreaks , Enterocolitis, Pseudomembranous/epidemiology , Intensive Care Units/statistics & numerical data , Aged , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Brazil/epidemiology , Clostridioides difficile/classification , Clostridioides difficile/drug effects , Clostridioides difficile/genetics , Cross Infection/microbiology , Diarrhea/microbiology , Drug Resistance, Bacterial/genetics , Electrophoresis, Gel, Pulsed-Field , Enterocolitis, Pseudomembranous/microbiology , Feces/microbiology , Humans , Incidence , Polymerase Chain Reaction/methods , Population Surveillance/methods , Ribotyping
17.
Crit Care ; 14(4): R152, 2010.
Article in English | MEDLINE | ID: mdl-20698966

ABSTRACT

INTRODUCTION: New challenges have arisen for the management of critically ill HIV/AIDS patients. Severe sepsis has emerged as a common cause of intensive care unit (ICU) admission for those living with HIV/AIDS. Contrastingly, HIV/AIDS patients have been systematically excluded from sepsis studies, limiting the understanding of the impact of sepsis in this population. We prospectively followed up critically ill HIV/AIDS patients to evaluate the main risk factors for hospital mortality and the impact of severe sepsis on the short- and long-term survival. METHODS: All consecutive HIV-infected patients admitted to the ICU of an infectious diseases research center, from June 2006 to May 2008, were included. Severity of illness, time since AIDS diagnosis, CD4 cell count, antiretroviral treatment, incidence of severe sepsis, and organ dysfunctions were registered. The 28-day, hospital, and 6-month outcomes were obtained for all patients. Cox proportional hazards regression analysis measured the effect of potential factors on 28-day and 6-month mortality. RESULTS: During the 2-year study period, 88 HIV/AIDS critically ill patients were admitted to the ICU. Seventy percent of patients had opportunist infections, median CD4 count was 75 cells/mm3, and 45% were receiving antiretroviral therapy. Location on a ward before ICU admission, cardiovascular and respiratory dysfunctions on the first day after admission, and the presence of severe sepsis/septic shock were associated with reduced 28-day and 6-month survival on a univariate analysis. After a multivariate analysis, severe sepsis determined the highest hazard ratio (HR) for 28-day (adjusted HR, 3.13; 95% CI, 1.21-8.07) and 6-month (adjusted HR, 3.35; 95% CI, 1.42-7.86) mortality. Severe sepsis occurred in 44 (50%) patients, mainly because of lower respiratory tract infections. The survival of septic and nonseptic patients was significantly different at 28-day and 6-month follow-up times (log-rank and Peto test, P < 0.001). CONCLUSIONS: Severe sepsis has emerged as a major cause of admission and mortality for hospitalized HIV/AIDS patients, significantly affecting short- and longer-term survival of critically ill HIV/AIDS patients.


Subject(s)
Acquired Immunodeficiency Syndrome/complications , HIV Infections/complications , Sepsis/mortality , AIDS-Related Opportunistic Infections/complications , AIDS-Related Opportunistic Infections/mortality , Acquired Immunodeficiency Syndrome/microbiology , Acquired Immunodeficiency Syndrome/mortality , Adult , Chi-Square Distribution , Critical Illness/mortality , Female , HIV Infections/microbiology , HIV Infections/mortality , Hospital Mortality , Humans , Intensive Care Units/statistics & numerical data , Male , Middle Aged , Multivariate Analysis , Proportional Hazards Models , Prospective Studies , Sepsis/complications , Shock, Septic/complications , Shock, Septic/mortality , Survival Analysis , Treatment Outcome
18.
Mem Inst Oswaldo Cruz ; 104(4): 531-48, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19722073

ABSTRACT

Corticosteroids are widely used to treat a diversity of pathological conditions including allergic, autoimmune and some infectious diseases. These drugs have complex mechanisms of action involving both genomic and non-genomic mechanisms and interfere with different signal transduction pathways in the cell. The use of corticosteroids to treat critically ill patients with acute respiratory distress syndrome and severe infections, such as sepsis and pneumonia, is still a matter of intense debate in the scientific and medical community with evidence both for and against its use in these patients. Here, we review the basic molecular mechanisms important for corticosteroid action as well as current evidence for their use, or not, in septic patients. We also present an analysis of the reasons why this is still such a controversial point in the literature.


Subject(s)
Adrenal Cortex Hormones/therapeutic use , Receptors, Glucocorticoid/drug effects , Respiratory Distress Syndrome/drug therapy , Shock, Septic/drug therapy , Clinical Trials as Topic , Evidence-Based Medicine , Genomics , Humans , Immunity, Innate/drug effects , Immunity, Innate/genetics , Molecular Chaperones/drug effects , Molecular Chaperones/genetics , Receptors, Glucocorticoid/genetics , Transcriptional Activation/drug effects , Transcriptional Activation/genetics
19.
Mem. Inst. Oswaldo Cruz ; 104(4): 531-548, July 2009. ilus, tab
Article in English | LILACS | ID: lil-523716

ABSTRACT

Corticosteroids are widely used to treat a diversity of pathological conditions including allergic, autoimmune and some infectious diseases. These drugs have complex mechanisms of action involving both genomic and non-genomic mechanisms and interfere with different signal transduction pathways in the cell. The use of corticosteroids to treat critically ill patients with acute respiratory distress syndrome and severe infections, such as sepsis and pneumonia, is still a matter of intense debate in the scientific and medical community with evidence both for and against its use in these patients. Here, we review the basic molecular mechanisms important for corticosteroid action as well as current evidence for their use, or not, in septic patients. We also present an analysis of the reasons why this is still such a controversial point in the literature.


Subject(s)
Humans , Adrenal Cortex Hormones/therapeutic use , Receptors, Glucocorticoid/drug effects , Respiratory Distress Syndrome/drug therapy , Shock, Septic/drug therapy , Clinical Trials as Topic , Evidence-Based Medicine , Genomics , Immunity, Innate/drug effects , Immunity, Innate/genetics , Molecular Chaperones/drug effects , Molecular Chaperones/genetics , Receptors, Glucocorticoid/genetics , Transcriptional Activation/drug effects , Transcriptional Activation/genetics
20.
Rev. bras. ter. intensiva ; 19(2): 186-191, abr.-jun. 2007. graf, tab
Article in Portuguese | LILACS | ID: lil-466815

ABSTRACT

JUSTIFICATIVA E OBJETIVOS: Os efeitos adversos da hipertensão intra-abdominal (PIA) são conhecidos há muitos anos, mas apenas recentemente deu-se importância à sua monitorização. Há evidências que cerca de um quarto dos centros de tratamento intensivo (CTI) não medem a PIA por falta de conhecimento da sua importância ou dificuldade na interpretação dos resultados. O objetivo deste estudo foi avaliar o conhecimento dos médicos sobre a síndrome de compartimento abdominal (SCA) e as características do seu manuseio. MÉTODO: Para a realização deste estudo foi enviado um questionário, contendo 12 perguntas sobre o assunto, para médicos que trabalham em CTI. RESULTADOS: O conhecimento das definições internacionais de SCA não parece estar influenciado pelo tempo de exercício da Medicina, mas sim pelo tempo de atividade dedicada à Medicina Intensiva. Embora a maioria esteja ciente da existência da SCA, menos da metade dos médicos que responderam ao questionário conhece as definições internacionais de 2004. A medida da PIA é realizada em pacientes com predisposição para SCA, por via intravesical, com injeção de 25 a 100 mL de líquido, com intervalos de 4 a 8 horas. Não parece existir valor de PIA (associado ou não a disfunções orgânicas) de consenso entre médicos desta pesquisa em relação ao tratamento clínico ou cirúrgico. CONCLUSÕES: O conhecimento sobre SCA é satisfatório quando considerados apenas os médicos que atuam majoritariamente em Medicina Intensiva. Contudo, é necessária a educação acerca da presença e gravidade da hipertensão intra-abdominal para grande parte dos médicos atuantes na Medicina Intensiva na região metropolitana do Rio de Janeiro.


BACKGROUND AND OBJECTIVES: The adverse effects of intra-abdominal hypertension are known for many years. Only recently proper attention has been given to routine intra-abdominal pressure (IAP) monitoring. There is evidence that a quarter of intensive care units (ICU) do not measure IAP, due to a lack of knowledge of its importance or difficulty in results interpretation. The aim of this study is investigate the knowledge of ICU physicians about abdominal compartimental syndrome and its management. METHODS: A questionnaire with 12 questions about this issue was mailed to ICU physicians. RESULTS: The current knowledge of the international definitions of ACS does not seem to be linked to the number of years of medical practice, but was associated with the time spent working on intensive care. Although most physicians are aware of the existence of ACS, less than half know the present international definitions. The IAP monitoring is performed in patients at risk for ACS, by means of the intravesical filling with 25 to 100 mL of liquids, in intervals varying from of 4 to 8 hours. There was no consensus on the value of IAP values (with or without organ dysfunctions) for the clinical or surgical treatments of ACS in this survey. CONCLUSIONS: The knowledge of ACS is satisfactory when we consider only physicians that devote most of their time to ICU work. However, it is necessary to improve education and knowledge of most intensive care physicians regarding the presence and severity of intra-abdominal hypertension in Rio de Janeiro.


Subject(s)
Laparotomy , Intensive Care Units
SELECTION OF CITATIONS
SEARCH DETAIL